Dear allstaters,
Role: Permanent SAS Programmer
Location: Belgium
Duties:
Collaboration on the analysis, interpretation and communication of
scientific investigations by creating quality, timely, cost-effective and
validated statistical programming products, focused on data analysis and
reporting.
=> Supporting the analysis of data gathered during the completion of
clinical trials, including the tabulation of patient data and study
findings.
Your profile
=> University Degree in Science.
=> Thorough knowledge of SAS (Knowledge of Splus would be an asset). 5 - 10
years experience
=> Excellent written and verbal English.
=> Previous experience in clinical research is a must.
We offer
=> A challenging opportunity in an innovative and growing company.
=> An opportunity to work on collaborative projects with major
pharmaceutical companies.
=> An attractive salary based on your profile and experience.
If this role is of interest please contact me for further details.
Or please forward this onto relevant persons who my find this role of
interest.
Mathew Hogan
Senior Consultant
Pharmaceutical, Biometrics & CRO Division
1st Pharma People
A Division of 1st-IT People
Tel: +44 (0) 207 255 6665
Fax: +44 (0) 207 255 6656
<mailto:[log in to unmask]>
mailto:[log in to unmask]
<http://www.1st-pharmapeople.com/> www.1st-pharmapeople.com
PLEASE NOTE: As of 31st May 2005 our office address will change to; 1st IT
People, 3rd Floor, Woolverstone House, 61-62 Berners Street, London. W1T
3NJ. As a result of this, we do have a new telephone number of 0207 255
6665. Please note our previous phone number will still work.
Offices in UK, Switzerland, The Netherlands & Hong Kong
This email is confidential and intended solely for the use of the individual
to whom it is addressed. Any views or opinions presented are solely those of
the author and do not represent those of the company from which the email
was sent. If you are not the intended recipient, be advised that you have
received this e-mail in error and that any use, dissemination forwarding,
printing or copying of this e-mail is strictly prohibited. While every
effort has been made to scan this e-mail, we can not accept any
responsibility for the loss of business or damage caused arising from this
email.
This email is confidential and intended solely for the use of the
individual to whom it is addressed. Any views or opinions presented are
solely those of the author and do not represent those of the company from
which the email was sent. If you are not the intended recipient, be advised
that you have received this e-mail in error and that any use, dissemination
forwarding, printing or copying of this e-mail is strictly prohibited.
While every effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
|